The United States healthcare ecosystem is witnessing a notable shift toward advanced neuromodulation therapies as the burden of neurological and psychiatric disorders continues to rise. Increasing cases of epilepsy, treatment-resistant depression, and chronic migraine are driving demand for innovative therapeutic approaches that go beyond traditional pharmaceuticals. Vagus nerve stimulation has...